The Treatment of Patients with Mood Disorders and Substance Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital.

Slides:



Advertisements
Similar presentations
13 Principles of Effective Addictions Treatment
Advertisements

Session 1: Overview of the Guidelines and Comorbidity
1 Concurrent Disorders An Introductory Learning Module for Post Secondary Institutions Concurrent Disorders Training Strategy Project.
1 The Child and Family Traumatic Stress Intervention A family based model for early intervention and secondary prevention Steven Berkowitz, M.D. Steven.
IzBen C. Williams, MD, MPH Instructor. Lecture - 11 MOOD DISORDERS.
Integrated Treatment of Co-Occurring Disorders
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Psychiatry in General Practice
BIPOLAR DISORDER What is Bipolar Disorder? We all experience changes in moods from time to time depending on events we go through in life. But when these.
1 Module 3 Understanding Mental Disorders, Treatment, and Recovery.
SCHIZOPHRENIA DISABILITIES POOR SOCIAL, FAMILY, AND WORK RELATIONSHIPS SIDE EFFECTS OF MEDICATION VIOLENCE WHEN IN PSYCHOTIC STATE SOCIAL STIGMA.
Challenges and Successes Treating Adolescent Substance Use Disorders Janet L. Brody, Ph.D. Center for Family and Adolescent Research (CFAR), Oregon Research.
Describe and Evaluate the Cognitive Treatment for Schizophrenia
By: Vanessa Ponce Period: 2 MOOD DISORDERS.  What is the difference between major depression and the bipolar disorder?  Can a mood disorder be inherited.
Guided Reading Activity 33
Illness Management and Recovery An Evidence-Based Practice.
Chapter 2 The Problem of Dual Diagnosis. Dual Diagnosis and Comorbidity Dual diagnosis – Describes individuals who meet diagnostic criteria for a mental.
Enhancing Co-Occurring Disorder Services in Addiction Treatment: Preliminary Findings of the Texas Co-Occurring State Incentive Grant Dartmouth Psychiatric.
Major Depressive Disorder Presenting Complaints
Section 4.3 Depression and Suicide Slide 1 of 20.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Copyright  West Institute Evidence-Based Practices ILLNESS MANAGEMENT AND RECOVERY EVIDENCE-BASEDPRACTICE An Introduction.
Depression in Adolescents and Young Adults: current best practice David Hartman Psychiatrist Child, Adolescent and Young Adult Service Institute of Mental.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Module 3 - Behavioral Interventions: Integrating Tobacco Use Interventions into Chemical Dependence Services.
Treatment 101 Substance Abuse Basics West Coast Consulting Wanda King
Integrated Treatment for Co-Occurring Disorders An Evidence-Based Practice.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Mood Disorders. Video – Out of the Shadows Handout with questions – –Descriptions –Contributing factors –Treatments –Your curiosity.
Dr. Saman Yousuf 17 June  Risk assessment and crisis management (if there is suicide risk) are covered in the same interview  Crisis management:
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
Treatment for Adolescents With Depression Study (TADS)
IzBen C. Williams, MD, MPH Instructor. Lecture - 8 MOOD DISORDERS.
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
Mental Disorders Mental Disorder- Is an illness that affects the mind and reduces person’s ability to function, adjust to change, or get along with others.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 32Clients with a Dual Diagnosis.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Texas COSIG Project Client and Service Characteristics Associated with Treatment Completion 4 th Annual COSIG Grantee Meeting March 2007.
ADOLESCENTS IN CRISIS: WHEN TO ADMIT FOR SELF-HARM OR AGGRESSIVE BEHAVIOR Kristin Calvert.
BIPOLAR DISORDER By Beth Atkinson & Hannah Tait. WHAT IS BIPOLAR DISORDER?  Bipolar disorder is a condition in which people go back and forth between.
RAMAR  SINCE 1980, RAMAR HAS BEEN A VITAL PART OF RECOVERY FOR CHRONICALLY ADDICTED RECOVERY FOR CHRONICALLY ADDICTED INDIVIDUALS IN NEED IN SUMMIT COUNTY.
Raymond F. Anton, MD for The COMBINE Study Research Group
+ Terrell Preventable Readmission Project Jeylan Buyukdura & Natalie Davies.
Mindtrap.
Depression Care Management Lessons from Project IMPACT _____________________________________________________ Jürgen Unützer, MD, MPH Professor and Vice.
Introduction Results and Conclusions Categorical group comparisons revealed no differences on demographic or social variables. At admission to treatment,
Mental Disorders & Resources for Help 7.MEH.3.1. Jacob Jacob is part of the local all-star baseball team. He just finished a long practice and decided.
Introduction Results and Conclusions On counselor background variables, no differences were found between the MH and SA COSPD specialists on race/ethnicity,
Texas COSIG Project Gender Differences in Substance Use Severity and Psychopathology in Clients with Co-Occurring Disorders 5 th Annual COSIG Grantee Meeting.
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
LO: To be able to describe and evaluate the Cognitive Treatment for Schizophrenia.
Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
Depression and Suicide Chapter 4.3. Health Stats What relationship is there between risk of depression and how connected teens feel to their school? What.
Bipolar Disorder- Assessment B
Development and Implementation of a Tobacco Cessation Toolkit
CRISIS RESOLUTION / HOME TREATMENT - DEFINITION
Do Alcoholics Respond to Placebo? Results from COMBINE
A systematic review of the relationship between substance abuse and psychotropic medication adherence: opportunities to improve outcomes for patients with.
Treating Alcohol Abuse
Consultant Psychiatrist and Research Fellow, IoPPN.
Describe and Evaluate the Cognitive Treatment for Schizophrenia
The Challenges of Bipolar Disorders
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Bipolar Disorder Abigail Kolbe.
Presentation transcript:

The Treatment of Patients with Mood Disorders and Substance Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital Professor of Psychiatry, Harvard Medical School Belmont, MA, USA

Likelihood of SUDs in people with psychiatric diagnoses (ECA) Diagnosis Odds ratio n Bipolar disorder6.6 n Schizophrenia4.6 n Panic disorder2.9 n Major depression1.9 n Anxiety disorder1.7

SUD in bipolar disorder n Lower medication adherence ■ More ■ Relapses ■ Hospitalizations ■ Homelessness ■ Suicide

Substance abuse in patients with psychiatric illness n Enhanced reinforcement n Mood change n Escape n Hopelessness n Poor judgment n Inability to appreciate consequences

The Self-Medication Hypothesis n Intolerance of specific emotions n The importance of a “drug of choice” n More useful in describing substance use rather than dependence

Diagnosing Psychiatric Disorders in Patients with SUDs  How long should you wait until a patient has been off all drugs and alcohol before you can diagnose any psychiatric disorder?  How much does diagnosis or primary vs. secondary depression matter?

Treatment of patients with SUD and mood disorder n Pharmacotherapy n Psychosocial treatment

Pharmacotherapy

Co-occurring disorder pharmacotherapy n Typically focuses on treatment of the psychiatric disorder, though more recent studies have focused on SUD as well n Choice of medication is typically based on the usual considerations n Side effect profile n Family history of medication response n Likelihood of medication adherence

McLean Hospital Study of Gender, Mood, and Recovery from Alcohol Dependence McLean Hospital Study of Gender, Mood, and Recovery from Alcohol Dependence (Greenfield et al., 1998) n Followed 101 patients (60 men, 41 women) hospitalized for alcohol dependence n Monthly assessment visits x 1 year n SCID diagnoses of MDD were made a) regardless of drinking and b) > 3 mos. abstinent

Depression and Gender as Predictors of Time to Relapse 1.00 Days Since Study Entry Chance of No Relapse Female, not dep Male, not dep Male, dep Female, dep

Relation of Depression and Discharge Antidepressants to Time to First Drink 1.00 Days Since Study Entry ( Greenfield et al., Arch Gen. Psychiatry, 1998 ) Chances of Abstinence No dep, discharge antidep Dep, discharge antidep Dep, no discharge antidep No dep, no discharge antidep

Medication studies of Medication studies of co-occurring SUDs and mood disorders n All trials have compared medication vs. placebo n No head-to-head studies of 2 active medications

Placebo Effect 1. Very strong in substance dependent populations 2. Difficult to distinguish between placebo effect & study participation effect, particularly in disorders involving voluntary behavior such as substance use disorders

15

Pharmacotherapy of SUD & Depression Pharmacotherapy of SUD & Depression n Most recent controlled studies show improvement in depression n Tricyclics have most robust effect n SSRIs most helpful in late-onset alcoholics, may worsen early-onset alcoholics n Less improvement in substance use (often correlated with mood improvement), but not worsening (ie, not enabling) n Pneumonia model

Valproate for Alcohol Dependence & BD n 24-week trial of valproate vs. placebo in 59 pts on lithium n Valproate patients had n Fewer heavy drinking days n Less drinking on heavy drinking days n No differences in manic, depressive sx Salloum et al., 2005

Medication adherence in patients with BD & SUD n Patients with BD & SUD were asked about lifetime adherence to various medications n Answers ranged from “never” to “all the time” n We compared “all the time” to other responses Weiss et al., 1998

Lifetime adherence

Reasons for med non-adherence Lithium ■ Physical effects n=29 ■ Saw no need for meds ■ Wanted to use substances Valproate ■ “Hassle” to take (lab tests) n=13 ■ Forgot ■ Wanted to use Benzodiazepines ■ Took more to get “high” n=21 ■ Impatient, so took more ■ Couldn’t think clearly

Reasons for non-adherence (cont’d) Neuroleptics ■ Physical effects (EPS) n=19 ■ Impatient, modify substance use, or get high ■ Saw no need TCAs ■ Impatient, so took more n=10 ■ Saw no need ■ Meds not working, so took less SSRIs ■ Wanted to use n=17 ■ Felt manic ■ Meds not working, so took less

Psychosocial Treatment

Models of dual diagnosis treatment  Sequential n Parallel n Integrated

Models of integrated treatment  Depends on the disorders & their relationship  “Integrated” treatment means different things to different people

Integrated Group Therapy (IGT): Core principles n Cognitive-behavioral model focuses on parallels between the disorders in recovery/relapse thoughts and behaviors n Interaction between the disorders n The single disorder paradigm: “bipolar substance abuse” n The central recovery rule

IGT structure n Check-in: substance use, mood, med adherence n Review last week’s group n Skill practice n Didactic/handout on integrated topic (e.g., dealing with depression without using alcohol and drugs) n Discussion

What is “integrated” about Integrated Group Therapy ? n Check-in focuses on mood, substance use, and medication adherence n Topics relevant to both disorders n Patients seen as having a single disorder: “bipolar substance abuse” n Relationship & similarities between the disorders & the recovery process stressed

Integrated Group Therapy: Sample topics n n Dealing with depression without using alcohol or drugs n Denial, ambivalence, acceptance n Taking medication n Self-help groups (for both SUD & BD) n Identifying and fighting triggers n Getting a good night’s sleep

The Central Recovery Rule No matter what n Don’t drink n Don’t use drugs n Take your medication as prescribed No matter what!

Findings of IGT research n 3 studies funded by National Institute on Drug Abuse n Compared IGT initially to either treatment as usual or standard manualized Group Drug Counseling (GDC) n All 3 studies showed significantly greater likelihood of abstinence in IGT patients n Fewer differences in mood outcomes

“Community-Friendly” Version of IGT vs. Group Drug Counseling

Making IGT more “community-friendly” n n IGT had had 2 successful studies, with 20 sessions led by therapists who had CBT and BD knowledge n n However, many community treatment programs don’t have counselors with experience in either CBT or BD, and can’t be paid for 20-session treatments n n These factors could reduce adoption of IGT in community treatment programs

Study of “Community-Friendly” version of IGT n n Made IGT more “community-friendly”   12 sessions, instead of 20   Groups were run by front-line drug counselors without formal CBT training or explicit BD knowledge n n Compared IGT to GDC Weiss et al., Drug and Alcohol Dependence, 2009

Patients n n 61 patients: 31 IGT & 30 GDC n n Current BD & substance dependence n n Substance use in the past 60 days n n A mood stabilizer regimen for ≥ 2 weeks

Results: Mood (p<.10)

Time to first abstinent month by treatment (p<.04) Month Abstinent (%) Baseline GDC IGT

Abstinence: IGT vs. GDC n ≥1 month abstinent: 71% vs. 40 %, p<.02 n Abstinent throughout treatment (3 mos.): 36% vs. 13%, p<.05

“Good clinical outcome” by treatment condition: Abstinent & no mood episodes in last month IGT GDC

Conducting an IGT Group

Structure of a 60-min. IGT session n Check-in/introductions (15’) n Review of last week’s group (5’) n Review of last week’s skill practice (5’) n Discuss session topic (20’) n Review session hand-out and wrap up (10’) n Hand out and discuss skill practice for next week (5’)

Conducting the check-in n Have you used drugs or alcohol during the past week? If so, on how many days? n How was your overall mood during the past week? n Did you take all of your medications as prescribed during the past week? If no, why not? n Did you face any high-risk situations or triggers in the past week? If yes, how did you deal with them?

Conducting the check-in (2) n Asking about how many days of use is important n Allows for assessment of improvement vs. worsening

Conducting the check-in (3) n The check-in establishes the tone of the group n It illustrates the “integrated” nature of IGT n Listen for the relevance of check-ins to the session topic n Come back to check-ins to illustrate session topic themes

Key principles of IGT n Parallels between the two disorders in the recovery and relapse processes n Interactions between the two disorders n The single disorder paradigm: “bipolar substance abuse” n The central recovery rule

Parallels in the recovery and relapse processes n The abstinence violation effect vs. stopping medication when depressed

Parallels in the recovery and relapse processes n Recovery vs. relapse thoughts and behaviors n “May as well thinking” vs. “It matters what you do” n Medication non-adherence vs. staying in bed all day vs. skipping AA

Combating hopelessness: “It matters what you do” Early sign of relapse to depression: not returning phone calls Early sign of relapse to depression: not returning phone calls One more call vs. one less call to make One more call vs. one less call to make Making concrete suggestions for taking one step at a time toward recovery Making concrete suggestions for taking one step at a time toward recovery You’re always on the road to getting better or getting worse; therefore, it matters what you do You’re always on the road to getting better or getting worse; therefore, it matters what you do

Interactions between the two disorders n Why use the term “bipolar substance abuse?” n “Drinking is bad for your mood” n “Playing around with your medication is bad for your addiction”

General guidelines for conducting IGT n Go back and forth between mood issues and substance use issues n Think about parallels: if a patient is talking about drinking, think about mood issues, and vice versa n Try to gently call on everyone, including people who are lost in their own thoughts n Be upbeat

General guidelines for conducting IGT (cont) n Focus on both successes and failures (“What did you do on the 4 days that you were sober that you didn’t do on the 3 days that you drank?)”

Therapist characteristics for IGT n Familiarity with SUD, BD ideal n Can be successfully run by front-line substance abuse counselors n Some knowledge of relapse prevention or CBT is very helpful n Empathic n Warm, friendly, non-confrontational

Who should be in an IGT group? n Willingness to enter a group that addresses both problems n Not acutely manic n Not intoxicated n IGT is designed to be delivered with pharmacotherapy as well; other psychosocial treatment is also encouraged

Adapting IGT to other settings n Change the length of the sessions n Add items to the check-in (e.g., exercise, self-help meeting attendance) n Add a preparation group n Broaden the population n Recite the central recovery rule at the end of the group n Use IGT principles in individual Rx

Current status of IGT n n Has been adapted for patients with psychotic illness as well n n In use in multiple clinical settings at McLean Hospital n n Currently in use in multiple clinical and research settings in U.S., Canada n n Book published in 2011 by Guilford Press

Now available!